Skip to Content

Oxymetazoline nasal Pregnancy and Breastfeeding Warnings

Oxymetazoline nasal is also known as: 12 Hour Nasal Decongestant, Afrin, Afrin Extra Moisturizing, Afrin NoDrip Sinus, Afrin Severe Congestion, Afrin Sinus, Dristan 12 Hour Nasal Spray, Duration, Four-Way Nasal Spray, Mucinex Sinus-Max Full Force, Mucinex Sinus-Max Moisture Smart, NRS Nasal, Neo-Synephrine 12 Hour, Nostrilla 12 Hour, Oxyfrin, Oxymeta-12, Sinarest Nasal, Sudafed OM Sinus Cold, Sudafed OM Sinus Congestion, Vicks QlearQuil 12 Hour Nasal Decongestant Moisturizing Spray, Vicks Sinex 12-Hour Decongestant Nasal Spray, Vicks Sinex 12-Hour Decongestant UltraFine Mist, Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist, Zicam Extreme Congestion Relief, Zicam Sinus Relief

Oxymetazoline nasal Pregnancy Warnings

Use should be avoided. US FDA pregnancy category: Not assigned

Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Oxymetazoline nasal Breastfeeding Warnings

Use should be avoided. Excreted into human milk: Data not available Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Afrin (oxymetazoline nasal)" Schering-Plough, Liberty Corner, NJ.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Afrin (oxymetazoline nasal)" Schering-Plough, Liberty Corner, NJ.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.